Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 8, 2025Blood

Real-world study of treatment landscape and safety outcomes of US patients with blastic plasmacytoid dendritic cell neoplasm

View Full Paper
Ask AI
Bookmark
Share

Authors

AKAmanda L. KongBFBoris Fishman

Discussion

Loading...

Member takes

Overview

Real-world data reveal treatment patterns and safety outcomes in blastic plasmacytoid dendritic cell neoplasm patients, indicating significant adverse events.

Key Points

  • Overall 11% of patients underwent stem cell transplant during follow up, indicating treatment challenges with blastic plasmacytoid dendritic cell neoplasm.
  • Common adverse events observed included anemia, neutropenia, and capillary leak syndrome, highlighting significant safety concerns.
  • Retrospective cohort analysis used electronic health records and medical claims data to assess treatment outcomes and patterns.
  • High prevalence of comorbidities among patients emphasizes the complexity of managing hematological malignancies.

Cite This Study

Kong et al. (2025) studied this question.

synapsesocial.com/papers/69362f3a4fa91c937236d39ehttps://doi.org/10.1182/blood-2025-4605
View Full Paper
Ask AI
Bookmark
Share